Despite the pharma pipeline having more than 50% more potential therapies than 10 years ago, investors remain cautious of the pharma sector, which showed just 1.7% return last year.
PM Live
Monday, 14 January 2008
Investors shun pharma
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment